How to choose a peptide: start with your goal, not the product. Ask whether an FDA-approved peptide treats that goal, then check whether any option has randomized trials in people. For weight loss, approved peptides have very strong evidence: tirzepatide 15 mg led to 20.9% average weight loss at 72 weeks in a trial of 2,539 adults.[2] For tendon healing, the most-promoted peptide, BPC-157, has 35 animal studies and one small clinical study behind it.[4] That gap is the most important thing to know before you choose.
This guide walks through the steps, gives an honest evidence grade for common goals, and lists questions to take to a clinician. We don’t name sellers or clinics. For basics first, read our beginner’s guide to peptides or browse the peptide basics hub.
Step 1: Name one specific goal
“Feel better” can’t be measured. “Lose 10% of my body weight,” “lower my A1C” or “recover from a tendon injury” can. A specific goal lets you find trials that measured that outcome, and it tells you later whether the treatment is working.
Step 2: Check for an approved option first
FDA approval means trials showed benefit for a specific use and FDA reviewed the manufacturing. Clinicians may also prescribe approved drugs off-label when medically appropriate.[8][9] If an approved peptide fits your goal, it’s usually the logical place to start. Our list of FDA-approved peptides shows what’s available.
Step 3: Grade the evidence honestly
We use four simple grades:
- A: FDA-approved for this goal, based on large randomized trials.
- B: Randomized human trials exist, but it isn’t approved for this goal.
- C: Small or early human studies only, often uncontrolled.
- D: Animal or lab studies only, or no published human data.
| Goal | Peptide options | Grade | Why |
|---|---|---|---|
| Weight loss | Semaglutide, tirzepatide, liraglutide | A | Semaglutide: 14.9% vs 2.4% weight loss at 68 weeks in 1,961 adults[1] |
| Weight loss | Retatrutide | B | Investigational; trials ongoing, not approved |
| Weight loss | AOD-9604 | D for use | Not approved anywhere; FDA advisers voted against compounding it |
| Belly fat in HIV lipodystrophy | Tesamorelin | A | Visceral fat fell 15.2% vs a 5.0% rise on placebo at 26 weeks[3] |
| Low sexual desire (premenopausal women) | PT-141 | A | Approved as Vyleesi for this condition only |
| Osteoporosis | Teriparatide, abaloparatide | A | Approved for high fracture risk |
| Tendon, muscle or joint injury | BPC-157 | C-D | 35 preclinical studies, 1 small clinical study, no clinical safety data[4] |
| Injury recovery | TB-500 | D | FDA found no studies of TB-500 given to people[5] |
| Muscle or growth hormone | Ipamorelin, CJC-1295, MK-677 | C-D | Small hormone studies; MK-677 is on FDA’s safety-risk compounding list[6] |
| Skin aging | GHK-Cu (topical) | C | Small cosmetic studies, many by the peptide’s developers[7] |
| Focus or anxiety | Semax, Selank | C | Mostly small Russian studies; not FDA-approved |
| Longevity | Epitalon | C-D | Nearly all research comes from one Russian group; few human studies |
The grades describe evidence for a goal, not the compound in general. Semaglutide is grade A for weight, but there’s no approval for using it to build muscle.
A worked example
Say your goal is to recover from a sore Achilles tendon. Online, BPC-157 and TB-500 come up first, often sold together. Run them through the steps:
- Approved option? No peptide is approved for tendon injuries. Standard care, such as a graded loading program with a physical therapist, is the evidence-based starting point.
- Human trials? For BPC-157, a systematic review found one small retrospective study of knee pain, in which 7 of 12 patients reported relief, alongside 35 animal and lab studies.[4] For TB-500, FDA found no human studies at all.[5]
- Safety data? The same review found no clinical safety data for BPC-157.[4]
- Grade: C-D at best.
That doesn’t mean you can’t discuss them with a clinician. It means the honest framing is “experimental, with unknown benefit and unknown risk,” and the conversation should start with treatments that have been tested. Our healing peptides hub covers this area in more depth.
Compare that with a goal like weight loss with obesity, where the same steps lead quickly to approved drugs with trials of thousands of people and well-described side effects.[1][2]
Step 4: Check safety and legal status
Look at each option’s profile for its status. FDA has placed several popular peptides in a “significant safety risk” category for compounding, citing concerns such as immune reactions, impurities and thin human data.[6] Rules were shifting in 2026; see are peptides legal? and the FDA peptide ban in 2026 for the latest.
Also think about form and route. Our guides to peptide nasal spray vs injection, peptide cream vs serum and lyophilized vs premixed peptides explain the practical differences.
Step 5: Compare head to head where you can
If you’re deciding between two options, our comparisons lay out the evidence side by side, for example semaglutide vs tirzepatide, BPC-157 vs TB-500, Selank vs Semax and GHK-Cu vs Matrixyl.
Step 6: Take these questions to a clinician
- What human trials support this peptide for my specific goal?
- Is there an approved treatment that would work as well or better?
- Is this product FDA-approved, compounded or neither? Which licensed pharmacy makes it?
- How does it interact with my conditions and current medicines?
- What side effects should I expect, and which ones mean I should call you?
- What lab tests do I need before and during treatment?
- What result, by when, would tell us it’s working? When do we stop if it isn’t?
- What does it cost, and is any of it covered by insurance?
Our peptide clinic vs DIY guide explains what good supervision looks like.
Red flags when choosing
- Claims that a peptide works for many unrelated problems at once.
- Evidence limited to testimonials, rodent studies or “clinical experience.”
- Products labeled “research use only” or “not for human consumption”; see research use only peptides.
- “Stacks” of several unapproved peptides, which makes side effects impossible to trace.
- Pressure to buy a long package up front.
Checklist: choosing a peptide
- One specific, measurable goal written down.
- Checked for an FDA-approved option for that goal.
- Evidence graded A to D for each option.
- Safety and legal status checked on the profile.
- Questions answered by a licensed clinician.
- A plan for when to reassess and when to stop.
The bottom line
The best peptide is the one with the strongest evidence for your exact goal and the fewest unknowns for your body. For weight, diabetes, bone loss and a few other conditions, that’s an approved drug. For most other goals, the honest answer today is that no peptide has been proven in people, and a good clinician will tell you so.
